company background image
SN. logo

Smith & Nephew LSE:SN. Stock Report

Last Price

UK£10.53

Market Cap

UK£9.2b

7D

-3.5%

1Y

-9.4%

Updated

18 Mar, 2024

Data

Company Financials +

SN. Stock Overview

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally.

SN. fundamental analysis
Snowflake Score
Valuation3/6
Future Growth4/6
Past Performance2/6
Financial Health4/6
Dividends3/6

Smith & Nephew plc Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Smith & Nephew
Historical stock prices
Current Share PriceUK£10.53
52 Week HighUK£13.17
52 Week LowUK£8.87
Beta0.51
1 Month Change-5.77%
3 Month Change0.38%
1 Year Change-9.38%
3 Year Change-22.84%
5 Year Change-29.62%
Change since IPO5,210.08%

Recent News & Updates

Is Smith & Nephew plc (LON:SN.) Trading At A 30% Discount?

Mar 16
Is Smith & Nephew plc (LON:SN.) Trading At A 30% Discount?

Recent updates

Is Smith & Nephew plc (LON:SN.) Trading At A 30% Discount?

Mar 16
Is Smith & Nephew plc (LON:SN.) Trading At A 30% Discount?

Capital Allocation Trends At Smith & Nephew (LON:SN.) Aren't Ideal

Feb 21
Capital Allocation Trends At Smith & Nephew (LON:SN.) Aren't Ideal

Is Smith & Nephew plc (LON:SN.) Trading At A 36% Discount?

Dec 15
Is Smith & Nephew plc (LON:SN.) Trading At A 36% Discount?

Is Smith & Nephew (LON:SN.) Using Too Much Debt?

Nov 30
Is Smith & Nephew (LON:SN.) Using Too Much Debt?

Smith & Nephew (LON:SN.) Could Be Struggling To Allocate Capital

Oct 29
Smith & Nephew (LON:SN.) Could Be Struggling To Allocate Capital

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price

Sep 11
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price

Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Aug 19
Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital

Jul 17
Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital

Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate

Jun 11
Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate

Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly

May 09
Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly

Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends

Apr 09
Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends

Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

Feb 09
Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

Nov 21
We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)

Nov 08
Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price

Oct 26
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well

Aug 11
These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well

There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital

Jul 28
There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 58% Above Its Share Price

Jun 26
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 58% Above Its Share Price

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Apr 29
Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Safely

Mar 26
These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Safely

Earnings Beat: Smith & Nephew plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 24
Earnings Beat: Smith & Nephew plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Smith & Nephew's (LON:SN.) Returns On Capital Not Reflecting Well On The Business

Jan 25
Smith & Nephew's (LON:SN.) Returns On Capital Not Reflecting Well On The Business

Are Investors Undervaluing Smith & Nephew plc (LON:SN.) By 30%?

Dec 02
Are Investors Undervaluing Smith & Nephew plc (LON:SN.) By 30%?

Smith & Nephew (LON:SN.) Might Be Having Difficulty Using Its Capital Effectively

Oct 23
Smith & Nephew (LON:SN.) Might Be Having Difficulty Using Its Capital Effectively

Smith & Nephew (LON:SN.) Could Easily Take On More Debt

Oct 09
Smith & Nephew (LON:SN.) Could Easily Take On More Debt

Shareholder Returns

SN.GB Medical EquipmentGB Market
7D-3.5%-1.5%0.5%
1Y-9.4%0.5%2.4%

Return vs Industry: SN. underperformed the UK Medical Equipment industry which returned 1.1% over the past year.

Return vs Market: SN. underperformed the UK Market which returned 2.7% over the past year.

Price Volatility

Is SN.'s price volatile compared to industry and market?
SN. volatility
SN. Average Weekly Movement2.9%
Medical Equipment Industry Average Movement7.4%
Market Average Movement4.7%
10% most volatile stocks in GB Market11.4%
10% least volatile stocks in GB Market2.5%

Stable Share Price: SN. has not had significant price volatility in the past 3 months.

Volatility Over Time: SN.'s weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
185618,452Deepak Nathhttps://www.smith-nephew.com

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.

Smith & Nephew plc Fundamentals Summary

How do Smith & Nephew's earnings and revenue compare to its market cap?
SN. fundamental statistics
Market capUK£9.18b
Earnings (TTM)UK£206.65m
Revenue (TTM)UK£4.36b

44.4x

P/E Ratio

2.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SN. income statement (TTM)
RevenueUS$5.55b
Cost of RevenueUS$1.66b
Gross ProfitUS$3.89b
Other ExpensesUS$3.63b
EarningsUS$263.00m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)0.30
Gross Margin70.14%
Net Profit Margin4.74%
Debt/Equity Ratio55.3%

How did SN. perform over the long term?

See historical performance and comparison

Dividends

2.8%

Current Dividend Yield

124%

Payout Ratio

Does SN. pay a reliable dividends?

See SN. dividend history and benchmarks
When do you need to buy SN. by to receive an upcoming dividend?
Smith & Nephew dividend dates
Ex Dividend DateMar 28 2024
Dividend Pay DateMay 22 2024
Days until Ex dividend9 days
Days until Dividend pay date64 days

Does SN. pay a reliable dividends?

See SN. dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.